CINECA IRIS Institutional Research Information System

TERZOLO, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.381
EU - Europa 22.118
AS - Asia 12.675
SA - Sud America 2.811
OC - Oceania 692
AF - Africa 621
Continente sconosciuto - Info sul continente non disponibili 29
Totale 61.327
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.729
IT - Italia 4.871
CN - Cina 4.320
DE - Germania 2.822
FR - Francia 1.879
GB - Regno Unito 1.626
ES - Italia 1.554
JP - Giappone 1.521
BR - Brasile 1.333
SG - Singapore 1.291
TR - Turchia 1.152
IE - Irlanda 1.129
SE - Svezia 1.111
PL - Polonia 873
NL - Olanda 865
CA - Canada 856
IN - India 785
KR - Corea 770
UA - Ucraina 764
FI - Finlandia 687
MX - Messico 678
AU - Australia 610
AR - Argentina 557
VN - Vietnam 467
CH - Svizzera 458
GR - Grecia 454
AT - Austria 434
CO - Colombia 391
PT - Portogallo 379
BE - Belgio 372
RU - Federazione Russa 350
HK - Hong Kong 327
IL - Israele 326
TW - Taiwan 274
RO - Romania 268
TH - Thailandia 266
ID - Indonesia 242
CL - Cile 224
MY - Malesia 209
DK - Danimarca 183
DZ - Algeria 161
HU - Ungheria 158
PH - Filippine 150
NO - Norvegia 143
PE - Perù 137
CZ - Repubblica Ceca 131
HR - Croazia 129
RS - Serbia 128
SA - Arabia Saudita 115
TN - Tunisia 102
EC - Ecuador 93
EG - Egitto 86
IR - Iran 83
NZ - Nuova Zelanda 78
SI - Slovenia 70
ZA - Sudafrica 68
PK - Pakistan 61
SN - Senegal 58
MA - Marocco 56
IQ - Iraq 55
BG - Bulgaria 52
SK - Slovacchia (Repubblica Slovacca) 42
AE - Emirati Arabi Uniti 41
VE - Venezuela 35
BA - Bosnia-Erzegovina 33
KE - Kenya 29
LT - Lituania 28
BY - Bielorussia 26
OM - Oman 26
MT - Malta 23
EU - Europa 21
LB - Libano 20
LV - Lettonia 20
CR - Costa Rica 19
PA - Panama 19
SY - Repubblica araba siriana 19
UZ - Uzbekistan 19
BD - Bangladesh 18
BO - Bolivia 17
DO - Repubblica Dominicana 16
UY - Uruguay 16
CY - Cipro 15
QA - Qatar 13
AM - Armenia 12
JO - Giordania 12
KZ - Kazakistan 12
MK - Macedonia 12
CU - Cuba 11
PR - Porto Rico 11
GT - Guatemala 10
GE - Georgia 9
KW - Kuwait 9
LK - Sri Lanka 9
ME - Montenegro 9
EE - Estonia 8
MU - Mauritius 8
NG - Nigeria 8
NP - Nepal 8
PY - Paraguay 8
TZ - Tanzania 8
Totale 61.200
Salva come PNG Salva come JPEG
Città #
Beijing 1.935
Chandler 1.736
Fairfield 1.160
Houston 1.089
Dublin 1.057
Singapore 1.013
Redwood City 891
Santa Clara 771
Ashburn 749
Woodbridge 613
Ann Arbor 593
Seattle 562
Wilmington 555
Torino 544
Cambridge 463
Warsaw 432
Milan 428
Jacksonville 412
Medford 345
Nyköping 343
Villeurbanne 338
Columbus 325
Rome 322
Madrid 309
Paris 307
Princeton 306
Buenos Aires 294
Pisa 290
Vienna 280
Istanbul 276
Würzburg 263
Tokyo 258
Turin 253
Shanghai 250
Guangzhou 242
New York 242
São Paulo 240
Ankara 229
Dong Ket 226
Dearborn 215
Munich 208
Athens 206
Barcelona 206
Rochester 206
Boston 184
London 178
Chicago 175
Los Angeles 173
Bogotá 171
Santiago 166
Jakarta 157
Berlin 148
Taipei 147
Hangzhou 141
Fremont 140
Toronto 138
Bangkok 133
Sydney 122
Bologna 120
Florence 120
San Diego 119
Brescia 118
Moscow 113
Montreal 112
Nanjing 108
Seoul 108
Budapest 107
Brussels 103
Brisbane 100
Amsterdam 99
Lima 99
Mexico City 99
Zurich 98
Helsinki 95
Chengdu 93
Porto 92
Rotterdam 89
Adelaide 88
Bethesda 86
Oslo 86
Birmingham 84
Belgrade 83
Lisbon 83
Philadelphia 82
Bucharest 81
Boardman 80
Pittsburgh 80
Frankfurt am Main 78
Central 77
Naples 73
Medellín 71
Kuala Lumpur 70
Rio de Janeiro 69
Padova 68
Valencia 68
Verona 68
San Francisco 67
Zagreb 67
Washington 64
Shenyang 63
Totale 27.883
Salva come PNG Salva come JPEG
Nome #
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. 11.312
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors 5.373
European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors 4.008
New perspectives for mitotane treatment of adrenocortical carcinoma 1.196
The Reticulin Algorithm for Adrenocortical Tumor Diagnosis: A Multicentric Validation Study on 245 Unpublished Cases. 1.122
Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study. 916
Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection. 816
Practical treatment using mitotane for adrenocortical carcinoma. 761
Hypertension and Acromegaly 740
Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma 712
Improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing's syndrome: A systematic review and meta-Analysis 710
Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior. 685
Autonomous hypercortisolism: definition and clinical implications 647
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study. 505
Long-term follow-up in adrenal incidentalomas: an Italian Multicenter Study. 485
Management of adrenal cancer: a 2013 update. 457
Oncocytic Adrenocortical Tumors: Diagnostic Algorithm and Mitochondrial DNA Profile in 27 Cases. 448
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. 432
Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical Carcinoma. 429
AME position statement on adrenal incidentaloma. 420
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study. 417
Comparison of Two Mitotane Starting dose Regimens in Patients with Advanced Adrenocortical Carcinoma. 404
Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacement. 383
Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas 376
ENSAT registry-based randomized clinical trials for adrenocortical carcinoma 370
Thyroid and colorectal cancer screening in acromegaly patients: Should it be different from that in the general population? 364
Management of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE) 363
Combination Chemotherapy in Advanced Adrenocortical Carcinoma. 361
Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification. 330
Management of adjuvant mitotane therapy following resection of adrenal cancer. 329
microRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations 327
18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma. 327
Prognostic Role of Overt Hypercortisolism in Completely Operated Patients with Adrenocortical Cancer 323
MITOTANE LEVELS PREDICT THE OUTCOME OF PATIENTS WITH ADRENOCORTICAL CARCINOMA TREATED ADJUVANTLY FOLLOWING RADICAL RESECTION. 323
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: A multicenter study 322
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma. 321
Merits and pitfalls of mifepristone in Cushing's syndrome 309
Screening of Cushing's Syndrome in Outpatients with Type 2 Diabetes: Results of a Prospective Multicentric Study in Italy. 300
Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas 296
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. 294
Diagnostic and prognostic role of steroidogenic factor 1 in adrenocortical carcinoma: a validation study focusing on clinical and pathologic correlates 281
Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis 270
Surgical remission of Cushing's syndrome reduces cardiovascular risk. 267
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma 263
RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization 257
Adjuvant mitotane treatment for adrenocortical carcinoma 251
Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines. 242
Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease 241
Analysis of BCLI, N363S and ER22/23EK polymorphisms of the glucocorticoid receptor gene in adrenal incidentalomas 239
Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma 233
Cortisol secretion, bone health, and bone loss: a cross-sectional and prospective study in normal nonosteoporotic women in the early postmenopausal period. 225
Assessment of glucocorticoid therapy with salivary cortisol in secondary adrenal insufficiency. 222
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 218
Abiraterone and increased survival in metastatic prostate cancer. 216
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 212
In vitro antitumor activity of progesterone in human adrenocortical carcinoma. 211
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma 204
Dual-Energy X-ray Absorptiometry Predictors of Vertebral Deformities in Beta-Thalassemia Major 190
Metronomic chemotherapy may be active in heavily pre-treated patients with metastatic adreno-cortical carcinoma. 189
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: a multicenter retrospective study. 189
Predictors of morbidity and mortality in acromegaly: an Italian survey. 187
Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function. 182
Diagnosi e terapia del carcinoma corticosurrenalico 182
Novel mutation of PPOX gene in a patient with abdominal pain and syndrome of inappropriate antidiuresis. 182
Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study 176
Growth hormone values after an oral glucose load do not add clinically useful information in patients with acromegaly on long-term somatostatin receptor ligand treatment. 174
Acromegaly is associated with increased cancer risk: a survey in Italy 172
Determination of salivary cortisol to assess time related changes of the adrenal response to stress in critically ill patients 169
Genetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 162
Analysis of BclI, N363S and ER22/23EK polymorphism of the glucocorticoid receptor gene in a large series of patients with adrenal incidentaloma 160
Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer. 160
18-Hydroxycorticosterone, 18-Hydroxycortisol, and 18-Oxocortisol in the Diagnosis of Primary Aldosteronism and Its Subtypes 158
24-hour profiles of blood pressure and heart rate in Cushing's syndrome. Evidence for differential control of cardiovascular variables by glucocorticoids. 156
Sorafenib may induce hypophosphatemia through a fibroblast growth factor-23 (FGF23)-independent mechanism. 156
Laboratory differentiation of Cushing's syndrome 154
Acute administration of melatonin at two opposite circadian stages does not change responses to gonadotropin releasing hormone, thyrotropin releasing hormone and ACTH in healthy adult males. 150
Insights on the natural history of adrenal incidentalomas 149
May an adrenal incidentaloma change its nature? 147
[Subclinical Cushing's syndrome in adrenal incidentalomas] 142
Adrenal incidentaloma, a five year experience. 140
A new simple HPLC method for measuring mitotane and its two principal metabolites Tests in animals and mitotane-treated patients 139
Long term safety of recombinant human growth hormone (rhGH) in patients treated during childhood 138
Adjunctive treatment of adrenocortical carcinoma 135
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study 130
Ribonucleotide Reductase Large Subunit (RRM1) Gene Expression May Predict Efficacy of Adjuvant Mitotane in Adrenocortical Cancer. 127
CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells 127
CYP2W1 Is Highly Expressed in Adrenal Glands and Is Positively Associated with the Response to Mitotane in Adrenocortical Carcinoma 126
Evaluation of midnight salivary cortisol as a predictor factor for common carotid arteries intima media thickness in patients with clinically inapparent adrenal adenomas 126
Biochemical stress evaluation after medial parapatellar and subvastus approach in total knee replacement. 124
Adrenocortical Carcinoma with Hypercortisolism. 124
Adrenal incidentalomas and subclinical Cushing's syndrome: is there evidence for glucocorticoid-induced osteoporosis? 120
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 120
What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life study 120
Efficacia del reintervento chirurgico in pazienti con carcinoma del cortico-surrene recidivo 118
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options. 116
Adrenal incidentalomas are tied to increased risk of diabetes: findings from a prospective study 116
[Drugs and andrological side-effects] 115
La recidiva di carcinoma del cortico-surrene:trattamento chirurgico o chemioterapico? 115
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 115
Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group. 114
Totale 49.356
Salva come PNG Salva come JPEG
Categoria #
all - tutte 125.464
article - articoli 0
book - libri 0
conference - conferenze 9.613
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 135.077
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.419 0 0 0 0 0 838 715 652 760 573 467 414
2020/20216.890 520 435 579 427 592 512 635 551 580 689 551 819
2021/20227.460 477 516 525 690 598 439 613 605 456 550 1.022 969
2022/202310.885 821 778 483 845 723 1.473 854 825 1.306 955 933 889
2023/20249.944 1.128 1.033 812 834 843 851 769 788 267 747 813 1.059
2024/20259.951 1.286 1.435 1.509 1.802 2.661 1.258 0 0 0 0 0 0
Totale 62.813